Drug Approval | March 18, 2024
Zydus receives USFDA approval for Finasteride and Tadalafil capsules
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ II, India
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ II, India
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day
Both organisations enter into a long- term collaboration to expand patient access in India
The company is confident of addressing the concern raised by the USFDA
Cureskin aims to disrupt the large and growing skin and hair care industry in India
Chlorpromazine Hydrochloride Injection is used to treat certain mental/mood disorders
The drug will target specific genetic mutations prevalent in certain types of cancers
This partnership marks a significant step for the Company towards establishing renewable energy power generation using hybrid open excess through solar and wind sources
From only 80 Jan Aushadhi Kendras in 2014, there are around 11,000 units operating across the country today
Venus Remedies' manufacturing unit, located in Baddi, Himachal Pradesh, has been recommended for supplying cephalosporin dry powder to UNICEF
Subscribe To Our Newsletter & Stay Updated
